Skip to main content

Table 3 Results of multinomial logistic regression with latent class as criterion

From: An observational study of response heterogeneity in children with attention deficit hyperactivity disorder following treatment switch to modified-release methylphenidate

 

High-start, mixed response vs. low-start, low response

High-start, first-phase response vs. low-start, low response

High-start, low-response vs. low-start, low response

High-start, mixed response vs. high-start, low response

High-start, first-phase response vs. high-start, low response

High-start, mixed response vs. high-start, first-phase response

β

OR

β

OR

β

OR

β

OR

β

OR

β

OR

Age (years)

–0.85a

0.43

–0.65a

0.52

–0.39a

0.68

–0.46

0.63

–0.26

0.77

–0.20

0.82

MPHpre (mg)

–1.18a

0.31

–0.73a

0.48

0.11

1.12

–1.29a

0.28

–0.84a

0.43

–0.46

0.63

MPHVisit 1 (mg)

–0.13

0.88

0.03

1.03

–0.15

0.87

0.02

1.02

0.18

1.19

–0.16

0.85

MPHVisit 2 (mg)

–0.07

0.94

–0.02

0.98

0.06

1.06

–0.12

0.88

–0.08

0.92

–0.04

0.96

Conduct problemsb

2.80a

16.40

1.93a

6.92

1.60a

4.97

1.19a

3.29

0.33

1.39

0.87a

2.38

Emotional symptomsc

–0.31

0.73

–0.26

0.77

0.17

1.18

–0.48

0.62

–0.42

0.66

–0.06

0.95

  1. High-start = subgroups with more severe symptoms compared with the low-start group at Visit 1; mixed-response = in parent ratings, comparatively stronger treatment response is observed during Visit 2 to Visit 3 and in teacher rating during Visit 1 to Visit 2; first-phase response = in parent and in teacher ratings comparatively stronger treatment response is observed during Visit 1 to Visit 2; low-response = compared with other subgroups only minor symptom reduction is detected during the observational period; for analyses, all covariates were z-transformed.
  2. β = regression coefficient; OR = odds ratio; MPH = methylphenidate; MPHpre = daily dose of MPH before switch to modified-release MPH; MPHVisit 1 = daily dose of modified-release MPH prescribed at Visit 1; MPHVisit 2 = daily dose of modified-release MPH prescribed at Visit 2.
  3. aα < 0.05.
  4. bConduct Problems Scale Strengths and Difficulties Questionnaire in parent ratings at Visit 1.
  5. cEmotional Symptoms Scale Strengths and Difficulties Questionnaire in parent ratings at Visit 1.